A novel drug developed in St. Louis for the treatment of rheumatoid arthritis is being investigated as a possible treatment for COVID-19. The anti-inflammatory drug, ATI-450, is informally named after drug maker Aclaris Therapeutics, Inc. with an assigned number. The…
“러시아 자체 개발 코로나19 백신 첫 임상시험 성공” Has Russia become the first country to develop a COVID-19 vaccine? Moscow says it has successfully completed trials on humans,… yet no further details on when the vaccine will be released were…
Emily Smith, MS CGC, Genetic Counselor at the Health Nucleus explains what’s included in the Genomic Clinical Report (GCR). Health Nucleus clients would receive their GCR after Return of Results (ROR) with their longevity physician. The GCR offers a comprehensive…
Infection prevention and treatment of COVID-19 Presented by Professor Tania Sorrell, Director, Marie Bashir Institute for Infectious Diseases and Biosecurity. Professor, Clinical Infectious Diseases and Deputy Dean (Clinical), Sydney Medical School. Director, Centre for Infectious Diseases and Microbiology, The Westmead…
US biotech firm Inovio on Tuesday reported encouraging results in preliminary clinical trials for its Covid-19 vaccine candidate. #Vaccine #Coronavirus #COVID19 #Inovio #DonaldTrump #WarpSpeed #INO4800 Follow us on: Website: Facebook: Twitter: Instagram:
